A detailed history of Covington Capital Management transactions in Dexcom Inc stock. As of the latest transaction made, Covington Capital Management holds 36 shares of DXCM stock, worth $2,888. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36
Holding current value
$2,888
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $2,748 - $3,390
36 New
36 $3,000
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $94 - $130
-1 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $106 - $143
1 New
1 $1,000
Q2 2021

Aug 13, 2021

SELL
$80.99 - $107.93 $80 - $107
-1 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$84.79 - $104.74 $84 - $104
1 New
1 $0
Q2 2019

Aug 15, 2019

SELL
$27.84 - $38.92 $807 - $1,128
-29 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$28.07 - $38.18 $814 - $1,107
29 New
29 $3,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Covington Capital Management Portfolio

Follow Covington Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Covington Capital Management with notifications on news.